ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction

AIMS: The prevalence of heart failure with preserved ejection fraction (HFpEF) is still increasing, and so far, no pharmaceutical treatment has proven to be effective. A key obstacle for testing new pharmaceutical substances is the availability of suitable animal models for HFpEF, which realisticall...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ESC Heart Fail
Autores principales: Schauer, Antje, Draskowski, Runa, Jannasch, Anett, Kirchhoff, Virginia, Goto, Keita, Männel, Anita, Barthel, Peggy, Augstein, Antje, Winzer, Ephraim, Tugtekin, Malte, Labeit, Siegfried, Linke, Axel, Adams, Volker
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524062/
https://ncbi.nlm.nih.gov/pubmed/32710530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12915
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares